Fox News - Fair & Balanced

Lorcaserin

�??????�?????�????�???�??�?� 
More Headlines »« Less Headlines

RelatedTopics

  1. Contrave
  2. FDA Alerts
  3. Unintended Pregnancy
  4. Amylin Pharmaceuticals
  5. Nutrition
  6. Birth Defect
Get updates on Lorcaserin
Weight loss drug Belviq gets overdue US launch

Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators.The Food and Drug Administration approved Belviq last June for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol. At the time, Belviq was the first new drug approved by the FDA for long-term weight loss in more than a decade.Despite only achieving modest weight loss in clinical studies, the drug was safe enough to win the FDA's endorsement, amid calls from doctors for new weight-loss treatmentsThe drug's launch was delayed for months by logistical hurdles, including classification by the Drug Enforcement Administration. According to the drug's label, Belviq will be classified as a Schedule IV controlled substance, which means it has a low potential for abuse. A small segment of patients in company studies reported experiencin...

Read More ›

  1. FDA will take 3 more months to review diet pill

    Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa, which could become the ...

  2. The biggest health stories of 2012

    This has been a very busy and occasionally dramatic year in the world of health. In addition to the usual crop of research news, food recalls, and celebrity headline...

  3. FDA Scrutinizes Weight Loss Pill From Orexigen

    Scientists for the Food and Drug Administration said Friday a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didn't mee...

  4. Experimental Drug Boosts Weight Loss

    An experimental obesity drug, taken along with formal counseling on lifestyle changes, may spur greater weight loss than counseling alone, a new study finds.The stud...

  5. FDA to Review First of Three New Weight Loss Drugs

    Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed w...

  6. FDA Panel Recommends Approval for Weight Loss Drug

    A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in gr...

  7. Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid

    The maker of a weight loss drug once seen as a potential blockbuster said it is scrapping its bid for U.S. approval because of "unprecedented" demands by regulators ...

  8. No Magic Pill: Weight-Loss Drugs Continue to Disappoint

    Users of Alli, the first weight-loss drug approved for sale over-the-counter in the United States, are finding what they likely suspected all along: pills are no mag...

  9. Diet Drug Faces U.S. Test After Rivals Fall Short

    The last of a trio of diet drug hopefuls faces scrutiny next week, after two rivals failed to convince U.S. regulators that marginal weight loss associated with thei...

  10. FDA Rejects Highly-Anticipated Diet Drug Qnexa

    Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss...

  11. FDA Panel Rejects Weight Loss Pill

    A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outwe...

  12. Stocks to Watch: Google, Merck, eBay

    Among the companies whose shares are expected to see active trading in Thursday's session are Google Inc., Merck & Co. and eBay Inc.Altria Group Inc. ( MO ) is expec...

  1. Consumer group urges FDA to reject Arena diet drug

    Watchdog group Public Citizen urged U.S. regulators on Tuesday not to approve Arena Pharmaceuticals Inc's experimental diet pill lorcaserin, citing concerns it could...

  2. FDA Staff Says Arena Diet Pill Linked to Cancer

    Arena Pharmaceuticals Inc.'s experimental diet pill may cause cancer and works only by a "slim margin," regulators said, sending shares down the most ever. The medic...

  3. New Diet Drug Called Safe and Effective in Study

    The results of a two-year study of a new weight loss drug, published in Thursday’s New England Journal of Medicine, show that lorcaserin aids in weight loss and is s...

  4. FDA panel recommends approval of obesity drug

    A Food and Drug Administration (FDA) advisory committee recommended Thursday the agency approve a new drug to treat obesity, the second time this year agency adviser...

  5. FDA panel to discuss Arena obesity drug

    An FDA advisory committee will meet in the second quarter to discuss Arena Pharmaceutical Inc's experimental obesity drug following the company's recent resubmission...

  6. U.S. Advisers Reject Arena Diet Drug; Shares Plunge

    Arena Pharmaceuticals Inc suffered a major setback on Thursday when U.S. advisers rejected its proposed weight-loss pill amid concerns that tumors in rats might indi...

  7. U.S. ponders heart safety trials for obesity drugs

    U.S. health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on the...

‹ Prev12Next ›